Pacific Biosciences Of California (PACB) Other Non-Current Assets (2010 - 2026)
Pacific Biosciences Of California (PACB) recorded quarterly Other Non-Current Assets of $1.6 million in Q1 2026, up 3.79% quarter-over-quarter from $1.5 million in Q4 2025, and down 28.44% on a YoY basis from $2.2 million in Q1 2025.
Pacific Biosciences Of California (PACB) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 28.44% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (down 28.44% YoY), while the FY2025 annual figure was $1.5 million, down 83.54% from the prior year.
- Other Non-Current Assets was $1.6 million for Q1 2026 at Pacific Biosciences Of California, up from $1.5 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $9.3 million in Q4 2024 to a low of $1.5 million in Q2 2025.
- Historically, Other Non-Current Assets has averaged $3.0 million across 5 years, with a median of $2.7 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets soared 241.84% in 2024, then tumbled 83.54% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $3.2 million in 2022, then slipped by 15.52% to $2.7 million in 2023, then jumped by 241.84% to $9.3 million in 2024, then sank by 83.54% to $1.5 million in 2025, then increased by 3.79% to $1.6 million in 2026.
- The last three Other Non-Current Assets figures came in at $1.6 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Pacific Biosciences Of California | 426.62 Mn | 150.66 Mn | 12.84 Mn | 1.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | 1.53 Mn |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.53 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Dec 31, 2024 | 9.31 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 2.26 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Dec 31, 2023 | 2.72 Mn |
| Sep 30, 2023 | 2.72 Mn |
| Jun 30, 2023 | 2.72 Mn |
| Mar 31, 2023 | 3.22 Mn |
| Dec 31, 2022 | 3.22 Mn |
| Sep 30, 2022 | 3.22 Mn |
| Jun 30, 2022 | 3.22 Mn |
| Mar 31, 2022 | 5.48 Mn |
| Dec 31, 2021 | 5.09 Mn |
| Jun 30, 2021 | 3.30 Mn |
| Mar 31, 2021 | 4.34 Mn |